Article
Genetic evaluation of HAND2 gene and its effects on thalidomide embryopathy.
Birth defects research - 1 Dec 2022
Rengel Bruna Duarte, Kowalski Thayne Woycinck, Bremm João Matheus, do Amaral Gomes Julia, Schüler-Faccini Lavínia, Vianna Fernanda Sales Luiz, Fraga Lucas Rosa
Abstract excerpt
BACKGROUND: HAND2 is a transcription factor important for embryonic development, required for limbs and cardiovascular development. Thalidomide is a drug responsible to a spectrum of congenital anomalies known as Thalidomide Embryopathy (TE), which includes mainly limb and heart defects. It is known that HAND2 interaction with TBX5, an important protein for limbs and heart development, is inhibited by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
